1. Home
  2. My blogs
  3. Recent results from the European Society of Cardiology meeting
September 15, 2011

Recent results from the European Society of Cardiology meeting

Brief clinical trial results from the recent ESC meeting in Paris:

ARISTOTLE: Apixaban (factor Xa inhibitor) bests warfarin in preventing stroke in patients with non-valvular atrial fibrillation.

PRODIGY: Increased bleeding complications in patients taking 24 vs. 6 months of dual anti platelet therapy (aspirin + clopidogrel).

CORP: Colchicine prevents recurrent pericarditis.

ISAR-CABG: DES drug-eluting stents) beat BMS (bare metal stents) in SVG's at one year.

dal-VESSEL: Dalcetrapib raises HDL cholesterol but not blood pressure.

RUBY-1: No benefit of using factor Xa inhibitor in ACS

Read all about it here: http://www.escardio.org/congresses/esc-2011/congress-news/Pages/welcome.aspx

03 9789 0088

Dr Greg Szto - 0438 231 165
Dr Vivek Gupta - 0431 025 021

FRANKSTON

Suite11
Peninsula Private Hospital
525 McClelland Drive

MORNINGTON

Consulting Suites
Beleura Private Hospital
925 Nepean Highway

ROSEBUD

Suite 8
Peninsula Medical Suites
1533 Pt Nepean Road

03 9789 0088

Dr Greg Szto - 0438 231 165
Dr Vivek Gupta - 0431 025 021

FRANKSTON

Suite11, Peninsula Private Hospital
525 McClelland Drive

MORNINGTON

Consulting Suites, Beleura Private Hospital
925 Nepean Highway

ROSEBUD

Suite 8, Peninsula Medical Suites
1533 Pt Nepean Road

Copyright © Peninsula Heart Centre 2020 | Website by Grendesign